Reduction of Immunosuppression as Initial Therapy for Post-Transplantation Lymphoproliferative Disorder

Reduction of immunosuppression (RI) is commonly used to treat post-transplant lymphoproliferative disorder (PTLD) in solid organ transplant recipients. We investigated the efficacy, safety and predictors of response to RI in adult patients with PTLD. 67 patients were managed with RI alone and 30 pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reshef, R, Vardhanabhuti, S, Luskin, MR, Heitjan, DF, Hadjiliadis, D, Goral, S, Krok, KL, Goldberg, LR, Porter, DL, Stadtmauer, EA, Tsai, DE
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3079420/
https://ncbi.nlm.nih.gov/pubmed/21219573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2010.03387.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados